USPH) Stock Technicals Hit Inflection Point

 

Decision Time: U.S. Physical Therapy Inc (NYSE:USPH) Stock Technicals Hit Inflection Point

 

U.S. Physical Therapy Inc technical rating as of

2017-04-23

(USPH Price of Stock at Publication: $64.2)


Decision Time: U.S. Physical Therapy Inc (NYSE:USPH) now sits in the perhaps the most difficult technical position — the stock has no urgency in its direction and that has left it at an inflection point. Watch the key moving average levels that we discuss below and further, watch the stochastics, technical oscillators and momentum readings for any kind of hint to direction.

The company has a three bull momentum rating which indicates an inflection point. It may seem obvious, but this is the time to put the stock on alert — a meaningful move in either direction now will likely swing momentum into a channel that could be decidedly up or down.

 
With the current stock price and the moving averages showing signs of indecision, any consecutive day stock move in either direction will likely push the stock into a bearish or bullish momentum channel that could persist for the short-term. This is a critical inflection point.

There are explosive trends shaping the world of technology right now and the stocks leading those trends can be identified. Tap Here to learn about CML’s Famed Top Picks.

 

USPH is down -6.6% over the last three months and up +4.6% over the last six months. The stock price is up +29.1% over the last year. The current stock price is $64.2.

The technical rating goes from a rating of one, the weakest upside technical, to a rating of five,
the highest upside technical. This is strictly focusing on price and technical — that means we focus on real-time stock price movement and then position it relative to the simple moving averages. To make the technical rating meaningful, the moving averages are also compared to each other.

If you’re looking for the simplest version of this, here it is — when the short-term moving averages are above the long-term moving averages that indicates relative strength in the technical. Then see the current price relative to the highest moving average and you will have a “back of the envelope” technical indicator in your back pocket for any stock at any time.

The blending and weighting of numbers above created the technical model built by Capital Market Laboratories (www.CMLviz.com).
Note the stock price at publication ($64.2), since the technical rating is based on intraday stock prices.
 

Technicals   |   Support: 63.15   |   Resistance: 65.35   

 

Golden Cross Alert: The 50 day MA is now above the 200 day moving average.

As we noted above — the back of the envelope rule here is that when shorter-term moving averages move above the longer-term ones, momentum is building. We have that right now.

Swing Death Cross Alert: The short-term 10 day moving average is now below the 50 day moving average.

Recall that when we see the shortest-term moving average (10-day in this case) fall below any other moving average (50-day in this case), it indicates weakening momentum.

We can set aside oscillators and stochastics, we are simply in no man’s land: U.S. Physical Therapy Inc has a three bull technical rating which puts it at an inflection point because while it’s trading above its 10 day moving average, its trading below both the 50- and 200 day simple moving averages and the 10 day moving average is below the 50 day moving average (“swing death cross”). The fact that the stock is up 0.31% today and that the stockprice is above the 10-day moving average puts it an a critical inflection point.
We now turn to the actual numbers driving this rating:

U.S. Physical Therapy Inc (NYSE:USPH) rating statistics:

10-day moving average: $63.97

50-day moving average: $69.15

200-day moving average: $65.29

Source link

U.S. Physical Therapy, Inc. (USPH) Upgraded at Zacks Investment Research


Zacks Investment Research upgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a sell rating to a hold rating in a research report sent to investors on Saturday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

USPH has been the subject of a number of other reports. Jefferies Group LLC set a $63.00 price target on U.S. Physical Therapy and gave the company a hold rating in a research report on Saturday, March 18th. Barrington Research downgraded U.S. Physical Therapy from an outperform rating to a market perform rating in a research report on Friday, March 17th.

Shares of U.S. Physical Therapy (NYSE:USPH) traded up 0.31% during midday trading on Friday, reaching $64.20. The company had a trading volume of 43,565 shares. U.S. Physical Therapy has a 12-month low of $48.71 and a 12-month high of $78.00. The stock has a market capitalization of $803.85 million, a PE ratio of 33.26 and a beta of 0.91. The stock’s 50 day moving average is $66.71 and its 200-day moving average is $66.88.

TRADEMARK VIOLATION NOTICE: This piece was posted by Markets Daily and is owned by of Markets Daily. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://www.themarketsdaily.com/2017/04/22/u-s-physical-therapy-inc-usph-upgraded-at-zacks-investment-research.html.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be given a $0.20 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.17. This represents a $0.80 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date is Wednesday, April 12th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 35.05%.

A number of hedge funds have recently added to or reduced their stakes in USPH. Sei Investments Co. increased its stake in U.S. Physical Therapy by 115.3% in the third quarter. Sei Investments Co. now owns 1,701 shares of the company’s stock worth $106,000 after buying an additional 911 shares in the last quarter. Acrospire Investment Management LLC increased its stake in U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock worth $115,000 after buying an additional 400 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new stake in U.S. Physical Therapy during the third quarter worth about $154,000. Tyers Asset Management LLC purchased a new stake in U.S. Physical Therapy during the fourth quarter worth about $166,000. Finally, Municipal Employees Retirement System of Michigan increased its stake in U.S. Physical Therapy by 1.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 2,770 shares of the company’s stock worth $174,000 after buying an additional 40 shares in the last quarter. 96.70% of the stock is owned by institutional investors and hedge funds.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.



Source link

U.S. Physical Therapy, Inc. (USPH) Upgraded to “Hold” by Zacks Investment Research


Zacks Investment Research upgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a sell rating to a hold rating in a research report report published on Saturday morning.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Several other research firms have also recently weighed in on USPH. Barrington Research cut U.S. Physical Therapy from an outperform rating to a market perform rating in a report on Friday, March 17th. Jefferies Group LLC set a $63.00 price target on U.S. Physical Therapy and gave the company a hold rating in a report on Saturday, March 18th.

U.S. Physical Therapy (NYSE:USPH) traded up 0.31% on Friday, reaching $64.20. The company’s stock had a trading volume of 43,565 shares. U.S. Physical Therapy has a one year low of $48.71 and a one year high of $78.00. The stock has a market cap of $803.85 million, a P/E ratio of 33.26 and a beta of 0.91. The stock has a 50-day moving average of $66.71 and a 200-day moving average of $66.88.

COPYRIGHT VIOLATION WARNING: “U.S. Physical Therapy, Inc. (USPH) Upgraded to “Hold” by Zacks Investment Research” was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/04/22/u-s-physical-therapy-inc-usph-upgraded-to-hold-by-zacks-investment-research.html.

The company also recently declared a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 1.25%. The ex-dividend date of this dividend is Wednesday, April 12th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.17. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 35.05%.

Institutional investors have recently made changes to their positions in the company. Sei Investments Co. boosted its position in shares of U.S. Physical Therapy by 115.3% in the third quarter. Sei Investments Co. now owns 1,701 shares of the company’s stock worth $106,000 after buying an additional 911 shares during the period. Acrospire Investment Management LLC boosted its position in shares of U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock worth $115,000 after buying an additional 400 shares during the period. Catalyst Capital Advisors LLC bought a new position in shares of U.S. Physical Therapy during the third quarter worth approximately $154,000. Tyers Asset Management LLC bought a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $166,000. Finally, Municipal Employees Retirement System of Michigan boosted its position in shares of U.S. Physical Therapy by 1.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 2,770 shares of the company’s stock worth $174,000 after buying an additional 40 shares during the period. Hedge funds and other institutional investors own 96.70% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH



Source link

U.S. Physical Therapy, Inc. (USPH) Stock Rating Upgraded by Zacks Investment Research


Zacks Investment Research upgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a sell rating to a hold rating in a research report sent to investors on Tuesday morning.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Other research analysts have also recently issued research reports about the company. Jefferies Group LLC set a $63.00 price target on U.S. Physical Therapy and gave the stock a hold rating in a research report on Saturday, March 18th. Barrington Research cut U.S. Physical Therapy from an outperform rating to a market perform rating in a research report on Friday, March 17th.

U.S. Physical Therapy (NYSE:USPH) opened at 64.00 on Tuesday. U.S. Physical Therapy has a 52 week low of $48.71 and a 52 week high of $78.00. The stock has a market cap of $801.34 million, a P/E ratio of 33.16 and a beta of 0.91. The stock has a 50 day moving average of $67.05 and a 200-day moving average of $66.87.

TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/04/21/u-s-physical-therapy-inc-usph-lifted-to-hold-at-zacks-investment-research-updated.html.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date is Wednesday, April 12th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.17. U.S. Physical Therapy’s payout ratio is currently 35.05%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Fund Advisors boosted its stake in U.S. Physical Therapy by 6.3% in the third quarter. BlackRock Fund Advisors now owns 927,868 shares of the company’s stock valued at $58,177,000 after buying an additional 54,747 shares during the period. Summit Global Investments purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $484,000. Schroder Investment Management Group boosted its stake in U.S. Physical Therapy by 209.2% in the third quarter. Schroder Investment Management Group now owns 319,373 shares of the company’s stock valued at $20,024,000 after buying an additional 216,073 shares during the period. Citadel Advisors LLC purchased a new stake in U.S. Physical Therapy during the third quarter valued at $530,000. Finally, Allianz Asset Management AG purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at $381,000. Hedge funds and other institutional investors own 96.70% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.



Source link

U.S. Physical Therapy, Inc. (USPH) Downgraded to “Sell” at Zacks Investment Research


Zacks Investment Research lowered shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a hold rating to a sell rating in a research note published on Wednesday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

USPH has been the subject of a number of other research reports. Jefferies Group LLC set a $63.00 price target on shares of U.S. Physical Therapy and gave the stock a hold rating in a report on Saturday, March 18th. Barrington Research downgraded shares of U.S. Physical Therapy from an outperform rating to a market perform rating in a report on Friday, March 17th.

U.S. Physical Therapy (NYSE:USPH) traded up 0.08% during mid-day trading on Wednesday, hitting $63.55. The company had a trading volume of 64,329 shares. The firm’s 50 day moving average is $67.77 and its 200 day moving average is $66.92. The company has a market capitalization of $795.71 million, a price-to-earnings ratio of 32.93 and a beta of 0.91. U.S. Physical Therapy has a 52 week low of $48.10 and a 52 week high of $78.00.

ILLEGAL ACTIVITY WARNING: “U.S. Physical Therapy, Inc. (USPH) Downgraded to “Sell” at Zacks Investment Research” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/04/19/u-s-physical-therapy-inc-usph-downgraded-by-zacks-investment-research-updated-updated.html.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.26%. The ex-dividend date is Wednesday, April 12th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.17. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 35.05%.

A number of institutional investors have recently modified their holdings of USPH. Cue Financial Group Inc. acquired a new position in shares of U.S. Physical Therapy during the third quarter valued at approximately $492,000. Albert D Mason Inc. boosted its stake in U.S. Physical Therapy by 78.7% in the third quarter. Albert D Mason Inc. now owns 54,588 shares of the company’s stock valued at $3,423,000 after buying an additional 24,044 shares during the period. Great West Life Assurance Co. Can boosted its stake in U.S. Physical Therapy by 2.6% in the third quarter. Great West Life Assurance Co. Can now owns 17,993 shares of the company’s stock valued at $1,127,000 after buying an additional 450 shares during the period. Capital Fund Management S.A. purchased a new stake in U.S. Physical Therapy during the third quarter valued at about $445,000. Finally, Wells Fargo & Company MN boosted its stake in U.S. Physical Therapy by 3.3% in the third quarter. Wells Fargo & Company MN now owns 45,464 shares of the company’s stock valued at $2,851,000 after buying an additional 1,438 shares during the period. 96.70% of the stock is owned by institutional investors.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.



Source link

U.S. Physical Therapy, Inc. (USPH) Stake Cut by Guggenheim Capital LLC


Guggenheim Capital LLC decreased its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 37.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,571 shares of the company’s stock after selling 8,105 shares during the period. Guggenheim Capital LLC owned about 0.11% of U.S. Physical Therapy worth $953,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Sei Investments Co. increased its stake in U.S. Physical Therapy by 115.3% in the third quarter. Sei Investments Co. now owns 1,701 shares of the company’s stock valued at $106,000 after buying an additional 911 shares during the last quarter. Acrospire Investment Management LLC increased its stake in U.S. Physical Therapy by 28.0% in the third quarter. Acrospire Investment Management LLC now owns 1,830 shares of the company’s stock valued at $115,000 after buying an additional 400 shares during the last quarter. Catalyst Capital Advisors LLC bought a new stake in U.S. Physical Therapy during the third quarter valued at about $154,000. Tyers Asset Management LLC bought a new stake in U.S. Physical Therapy during the fourth quarter valued at about $166,000. Finally, Municipal Employees Retirement System of Michigan increased its stake in U.S. Physical Therapy by 1.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 2,770 shares of the company’s stock valued at $174,000 after buying an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company’s stock.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) opened at 63.50 on Wednesday. The firm’s 50-day moving average price is $67.77 and its 200 day moving average price is $66.92. U.S. Physical Therapy, Inc. has a 12-month low of $48.10 and a 12-month high of $78.00. The firm has a market cap of $795.08 million, a P/E ratio of 32.90 and a beta of 0.91.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 5th. Stockholders of record on Monday, April 17th will be paid a $0.20 dividend. The ex-dividend date is Wednesday, April 12th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.17. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.26%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 35.05%.

ILLEGAL ACTIVITY NOTICE: “U.S. Physical Therapy, Inc. (USPH) Stake Cut by Guggenheim Capital LLC” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/04/19/u-s-physical-therapy-inc-usph-stake-cut-by-guggenheim-capital-llc.html.

Several analysts have issued reports on USPH shares. Zacks Investment Research upgraded U.S. Physical Therapy from a “sell” rating to a “buy” rating and set a $79.00 price objective on the stock in a report on Friday, January 6th. Jefferies Group LLC set a $63.00 price objective on U.S. Physical Therapy and gave the stock a “hold” rating in a report on Saturday, March 18th. Finally, Barrington Research downgraded U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, March 17th.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.



Source link

Robbins Arroyo LLP: U.S. Physical Therapy, Inc. (USPH) Misled Shareholders According to a Recently Filed Class Action


SAN DIEGO & HOUSTON–()–Shareholder rights law firm Robbins Arroyo LLP announces
that a class action complaint was filed against U.S. Physical Therapy,
Inc. (NYSE: USPH) (“USPH”) in the U.S. District Court for the Southern
District of New York. The complaint is brought on behalf of all
purchasers of USPH securities between May 8, 2014 and March 16, 2017,
for alleged violations of the Securities Exchange Act of 1934 by USPH’s
officers and directors. USPH operates outpatient physical and
occupational therapy clinics for pre- and post-operative care for a
variety of orthopedic-related disorders and sports-related injuries,
rehabilitation of injured workers, and preventative care.

View this information on the law firm’s Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/u-s-physical-therapy-inc

U.S. Physical Therapy Accused of Failing to Disclose Material
Weakness in its Internal Controls

According to the complaint, in a series of filings with the U.S.
Securities Exchange Commission, USPH officials attested to the accuracy
of the company’s financial statements, the effectiveness of the internal
controls, and the disclosure of all fraud. On August 7, 2014, USPH
issued a press release stating that it was raising its 2014 earnings
guidance, net income had increased compared to the same period in the
prior year, and net revenues had increased. In commenting on these
results, Chris Reading, USPH’s Chief Executive Officer, stated, “Our
Fit2WRK group continues to land terrific employer accounts which have
assisted us in further improving our payor base while also driving new
customers into our many partnerships around the country.” However, the
complaint alleges that USPH officials failed to disclose that the
company had a material weakness in its internal controls over accounting
and financial reporting, that the company’s improper accounting resulted
in violations of Generally Accepted Accounting Principles, and as a
result, the company’s financial statements were inaccurate and
unreliable.

On March 16, 2017, USPH announced that its historical accounting for
redeemable non-controlling interests of acquired partnerships was
incorrect, and that the error would result in unreliable financial
statements for the years ended December 31, 2015 and 2014, all quarters
within 2014 and 2015, and the first three quarters of 2016. USPH further
disclosed that it would restate certain figures for the affected
periods, and that it would need to file a Notification of Late Filing
for its Annual Report on Form 10-K for the year ended December 31, 2016,
which it expected to file on or before March 31, 2017. On this news,
USPH’s stock fell $3.85 per share, or 5.2%, to close at $69.90 per share
on March 16, 2017.

U.S. Physical Therapy Shareholders Have Legal Options

Concerned shareholders who would like more information about their
rights and potential remedies can contact attorney Leonid Kandinov at
(800) 350-6003, LKandinov@robbinsarroyo.com,
or via the shareholder
information form
on the firm’s website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder
rights law. The firm represents individual and institutional investors
in shareholder derivative and securities class action lawsuits, and has
helped its clients realize more than $1 billion of value for themselves
and the companies in which they have invested.

Attorney Advertising. Past results do not guarantee a similar outcome.



Source link

U.S. Physical Therapy, Inc. (USPH) Ex-Dividend Date Scheduled for April 12, 2017


U.S. Physical Therapy, Inc. ( USPH ) will begin trading ex-dividend on April 12, 2017. A cash dividend payment of $0.2 per share is scheduled to be paid on May 05, 2017. Shareholders who purchased USPH prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 17.65% increase over prior dividend payment.

The previous trading day’s last sale of USPH was $63.95, representing a -18.01% decrease from the 52 week high of $78 and a 37.85% increase over the 52 week low of $46.39.

USPH is a part of the Health Care sector, which includes companies such as Walgreens Boots Alliance, Inc. ( WBA ) and CVS Health Corporation ( CVS ). USPH’s current earnings per share, an indicator of a company’s profitability, is $1.94. Zacks Investment Research reports USPH’s forecasted earnings growth in 2016 as 8.47%, compared to an industry average of 6.4%.

For more information on the declaration, record and payment dates, visit the USPH Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



Source link

U.S. Physical Therapy Inc. (USPH) Moves Higher on Volume Spike for April 07


U.S. Physical Therapy Inc. (USPH) traded on unusually high volume on Apr. 07, as the stock
gained 2.02% to close at $63.15. On the day, U.S. Physical Therapy Inc. saw 125,702 shares trade hands on 990 trades.
Considering that the stock averages only a daily volume of 72,921 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the
company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $78.00 and $46.39 over the last 52-weeks, its 50-day SMA is now $70.40, and its 200-day SMA $64.94. U.S. Physical Therapy Inc.
has a P/B ratio of 4.42. It also has a P/E ratio of 31.9.

US Physical Therapy Inc operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others.

Headquartered in Houston, TX, U.S. Physical Therapy Inc. has 3,400 employees and is currently under the leadership of CEO Christopher J. Reading.

For a complete fundamental analysis analysis of U.S. Physical Therapy Inc., check out Equities.com’s Stock Valuation Analysis report
for USPH
.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to
learn more about Guild Investment’s Market Commentary and Adam Sarhan’s
Find Leading Stocks
today.


To get more information on U.S. Physical Therapy Inc. and to follow the company’s latest updates, you can visit the company’s profile page here:
USPH’s Profile
. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
Newsdesk
. Also, don’t forget to sign-up for our daily
email newsletter
to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Source link

U.S. Physical Therapy Inc. (USPH) Moves Lower on Volume Spike for April 06


U.S. Physical Therapy Inc. (USPH) traded on unusually high volume on Apr. 06, as the stock
lost 0.8% to close at $61.90. On the day, U.S. Physical Therapy Inc. saw 118,746 shares trade hands on 1,324 trades.
Considering that the stock averages only a daily volume of 70,274 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the
company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $78.00 and $46.39 over the last 52-weeks, its 50-day SMA is now $70.53, and its 200-day SMA $64.92. U.S. Physical Therapy Inc.
has a P/B ratio of 4.34. It also has a P/E ratio of 32.2.

US Physical Therapy Inc operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others.

Headquartered in Houston, TX, U.S. Physical Therapy Inc. has 3,400 employees and is currently under the leadership of CEO Christopher J. Reading.

For a complete fundamental analysis analysis of U.S. Physical Therapy Inc., check out Equities.com’s Stock Valuation Analysis report
for USPH
.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to
learn more about Guild Investment’s Market Commentary and Adam Sarhan’s
Find Leading Stocks
today.


To get more information on U.S. Physical Therapy Inc. and to follow the company’s latest updates, you can visit the company’s profile page here:
USPH’s Profile
. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
Newsdesk
. Also, don’t forget to sign-up for our daily
email newsletter
to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Source link